The programme targets digital health solutions in low‑income settings, aligning with the e‑pharmacy platform’s goal to improve prescription drug access in Nigeria. As a non‑dilutive grant, it matches the founder’s need for early‑stage funding without equity dilution, though the broad eligibility may increase competition.